Skip to main content
. 2022 Apr 26;10:862294. doi: 10.3389/fcell.2022.862294

FIGURE 6.

FIGURE 6

FAMscore and prognosis in immunotherapy. (A–B) Association of FAMscore with progression-free survival (PFS) in Kaplan–Meier survival analyses in the NSCLC-1 (A) and NSCLC-2 (B) cohorts. (C–D) Association of FAM score with PFS in multivariate Cox models in the NSCLC-1 (C) and NSCLC-2 (D) cohorts. (E–F) Association of FAMscore with overall survival in the Kaplan–Meier survival analysis (E) and multivariate Cox model of the melanoma cohort (F). NSCLC: non-small-cell lung cancer; ECOG PS: Eastern Cooperative Oncology Group performance status; TPS: tumor proportion score.